Affirming support for most-favored-Nation drug pricing for United States patients.

House Resolution

H.Res. 928

119th Congress

Affirming support for most-favored-Nation drug pricing for United States patients.

In Committee

Introduced:Dec 4, 2025

Primary Sponsor

Debbie Dingell

D - MI

Cosponsors

1

Quick Stats

Policy Area

Health

Summary

This bipartisan resolution affirms support for most-favored-nation drug pricing, which would align U.S. prescription drug prices with those paid in other developed nations. It notes that U.S. drug prices are 2.78 times higher than comparison countries, with Americans spending over $1,400 per capita annually on prescriptions.

Latest Action

Referred to the House Committee on Energy and Commerce.

AI Summary

Plain-English explanation of this bill

This bipartisan resolution affirms support for most-favored-nation drug pricing, which would align U.S. prescription drug prices with those paid in other developed nations. It notes that U.S. drug prices are 2.78 times higher than comparison countries, with Americans spending over $1,400 per capita annually on prescriptions.

Last updated: 12/27/2025

Key Points

Main provisions of the bill

U.S. drug prices are 2.78 times higher than comparable countries
Americans spend over $1,400 per capita annually on prescription drugs
21% of adults have not filled prescriptions due to cost
Supports aligning U.S. prices with lowest prices in developed nations
References Trump Executive Order on most-favored-nation pricing
Endorses expanding Medicare drug price negotiation

How This Impacts Americans

Potential effects on citizens and communities

Directly impacts all Americans purchasing prescription medications, particularly those rationing medications due to cost, Medicare beneficiaries, and patients with chronic conditions requiring ongoing prescriptions. Could significantly affect pharmaceutical industry revenue models.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

928, 119th Congress (2025). "Affirming support for most-favored-Nation drug pricing for United States patients.". Source: Voter's Right Platform. https://votersright.org/bills/119-hres-928